Clearside Biomedical (CLSD) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CLSD Hot Sheet
Join SI Premium – FREE
Clearside Biomedical (NASDAQ: CLSD) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's Muse AI to counter China models with subscribers, not ads, Alexandr Wang says - Nikkei
- Deckers Outdoor (DECK) PT Lowered to $100 at Williams Trading
- Dr Reddy's Rolls Out New Generic Ozempic Brands To Ease Obeda Supply Hit - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
